Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ida Martinelli

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Blood|July 14, 2018
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndromeVittorio Pengo, Gentian Denas, Giacomo Zoppellaro, et al.
Nature Microbiology|September 25, 2019
A human antithrombin isoform dampens inflammatory responses and protects from organ damage during bacterial infectionPraveen Papareddy, Madlen Rossnagel, Femke Doreen Hollwedel, et al.
Systematic Reviews|June 28, 2014
Low-molecular-weight heparin for prevention of placenta-mediated pregnancy complications: protocol for a systematic review and individual patient data meta-analysis (AFFIRM)Marc A Rodger, Nicole J Langlois, Johanna Ip de Vries, et al.
Blood Advances|August 1, 2022
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis studyGualtiero Palareti, Daniela Poli, Walter Ageno, et al.
Blood Advances|April 19, 2022
Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort studyWalter Ageno, Jan Beyer Westendorf, Laura Contino, et al.
Lancet (London, England)|October 11, 2016
Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trialsMarc A Rodger, Jean-Christophe Gris, Johanna I P de Vries, et al.
American Journal of Hematology|July 22, 2014
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net studyIda Martinelli, Valerio De Stefano, Alessandra Carobbio, et al.
JAMA Internal Medicine|July 14, 2015
Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International RegistryWalter Ageno, Nicoletta Riva, Sam Schulman, et al.
The Lancet. Haematology|August 18, 2019
Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studiesPaul Monagle, Anthonie W A Lensing, Kirstin Thelen, et al.
Journal of Thrombosis and Haemostasis : JTH|April 5, 2020
Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluationGuy Young, Anthonie W A Lensing, Paul Monagle, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Blood|July 14, 2018
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndromeVittorio Pengo, Gentian Denas, Giacomo Zoppellaro, et al.
Nature Microbiology|September 25, 2019
A human antithrombin isoform dampens inflammatory responses and protects from organ damage during bacterial infectionPraveen Papareddy, Madlen Rossnagel, Femke Doreen Hollwedel, et al.
Systematic Reviews|June 28, 2014
Low-molecular-weight heparin for prevention of placenta-mediated pregnancy complications: protocol for a systematic review and individual patient data meta-analysis (AFFIRM)Marc A Rodger, Nicole J Langlois, Johanna Ip de Vries, et al.
Blood Advances|August 1, 2022
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis studyGualtiero Palareti, Daniela Poli, Walter Ageno, et al.
Blood Advances|April 19, 2022
Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort studyWalter Ageno, Jan Beyer Westendorf, Laura Contino, et al.
Lancet (London, England)|October 11, 2016
Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trialsMarc A Rodger, Jean-Christophe Gris, Johanna I P de Vries, et al.
American Journal of Hematology|July 22, 2014
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net studyIda Martinelli, Valerio De Stefano, Alessandra Carobbio, et al.
JAMA Internal Medicine|July 14, 2015
Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International RegistryWalter Ageno, Nicoletta Riva, Sam Schulman, et al.
The Lancet. Haematology|August 18, 2019
Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studiesPaul Monagle, Anthonie W A Lensing, Kirstin Thelen, et al.
Journal of Thrombosis and Haemostasis : JTH|April 5, 2020
Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluationGuy Young, Anthonie W A Lensing, Paul Monagle, et al.
Pageof 15